Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines – does scheduling matter?

References

• Chakravarti A, Erkkinen MG, Nestler U, Stupp R, Mehta M, Aldape K, Gilbert MR, Black PM, Loeffler JS. 2006. Temozolomide-mediated radiation enhancement in glioblastoma: A report on underlying mechanisms. Clinical Cancer Research 12:4738–4746.
   PubMed Web of Science ®Google Scholar
• Chalmers AJ, Ruff EM, Martindale C, Lovegrove N, Short SC. 2009. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. International Journal of Radiation Oncology*Biology*Physics 75:1511–1519.
   Google Scholar
• Combs S, Zipp L, Rieken S, Habermehl D, Brons S, Winter M, Haberer T, Debus J, Weber K-J. 2012. In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells. Radiation Oncology 7:9.
   PubMed Web of Science ®Google Scholar
• Combs SE, Bohl J, Elsässer T, Weber K-J, Schulz-Ertner D, Debus J, Weyrather WK. 2009. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines. International Journal of Radiation Biology 85:126–137.
   PubMed Web of Science ®Google Scholar
• Fritz G, Tano K, Mitra S, Kaina B. 1991. Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments. Molecular and Cellular Biology 11:4660–4668.
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. 2005. MGMT gene silencing and benefit from temozolomide in glioblastoma. New England Journal of Medicine 352:997–1003.
   PubMed Web of Science ®Google Scholar
• Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, Kaina B, Weller M. 2006. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. Journal of Neurochemistry 96:766–776.
   PubMed Web of Science ®Google Scholar
• Kitabayashi H, Shimada H, Yamada S, Yasuda S, Kamata T, Ando K, Tsujii H, Ochiai T. 2006. Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation. Oncology Reports 15:913–918.
   PubMed Web of Science ®Google Scholar
• Kondo N, Takahashi A, Ono K, Ohnishi T. 2010. DNA damage induced by alkylating agents and repair pathways. Journal of Nucleic Acids 2010 (Article ID 543531).
   PubMedGoogle Scholar
• Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, Stupp R. 2004. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clinical Cancer Research 10:3728–3736.
   PubMed Web of Science ®Google Scholar
• Patel M, McCully C, Godwin K, Balis FM. 2003. Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates. Journal of Neuro-Oncology 61:203–207.
   PubMed Web of Science ®Google Scholar
• Quiros S, Roos WP, Kaina B. 2010. Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle 9:168–178.
   PubMed Web of Science ®Google Scholar
• Roos WP, Batista LFZ, Naumann SC, Wick W, Weller M, Menck CFM, Kaina B. 2007. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 26:186–197.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine 352:987–996.
   PubMed Web of Science ®Google Scholar
• van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ. 2000. Survival of human glioma cells treated with various combination of temozolomide and X-rays. International Journal of Radiation Oncology*Biology*Physics 47:779–784.
   Google Scholar
• Walker MD, Strike TA, Sheline GE. 1979. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. International Journal of Radiation Oncology*Biology*Physics 5:1725–1731.
   Google Scholar
• Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, et al. 1980. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New England Journal of Medicine 303:1323–1329.
   PubMed Web of Science ®Google Scholar
• Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES. 1997. In vitro evaluation of temozolomide combined with X-irradiation. Anti-Cancer Drugs 8:92–97.
   PubMed Web of Science ®Google Scholar